eMagin Stock Forecast, Price & News

-0.22 (-7.41 %)
(As of 08/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume351,349 shs
Average Volume1.78 million shs
Market Capitalization$198.75 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EMAN News and Ratings via Email

Sign-up to receive the latest news and ratings for eMagin and its competitors with MarketBeat's FREE daily newsletter.

eMagin logo

About eMagin

eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode (OLED) miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL. The company also provides design reference kits, which include a micro display and associated electronics to help original equipment manufacturers (OEMs) to evaluate micro display products; near-eye virtual imaging modules that incorporate its OLED-on-silicon micro displays with its lenses and electronic interfaces for integration into OEM products; prism optics, a molded plastic prism lens that permits its AMOLED micro displays to provide realistic images that can be viewed for extended periods with reduced eye-fatigue; and driver boards. Its products are used in military aviation helmets, military weapons sights and targeting systems, night vision and thermal imaging devices, training and simulation, visualization for ocular surgery, mobile ultrasound, and augmented reality applications. eMagin Corporation was founded in 1996 and is headquartered in Hopewell Junction, New York.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.72 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

eMagin (NYSEAMERICAN:EMAN) Frequently Asked Questions

Is eMagin a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for eMagin in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" eMagin stock.
View analyst ratings for eMagin
or view top-rated stocks.

What stocks does MarketBeat like better than eMagin?

Wall Street analysts have given eMagin a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but eMagin wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting eMagin?

eMagin saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 3,600,000 shares, an increase of 20.8% from the May 31st total of 2,980,000 shares. Based on an average daily trading volume, of 1,720,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 5.5% of the company's stock are sold short.
View eMagin's Short Interest

When is eMagin's next earnings date?

eMagin is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for eMagin

How were eMagin's earnings last quarter?

eMagin Co. (NYSEAMERICAN:EMAN) announced its earnings results on Wednesday, March, 17th. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.03) by $0.02. The semiconductor company had revenue of $7.68 million for the quarter, compared to analyst estimates of $7.50 million. eMagin had a negative trailing twelve-month return on equity of 41.74% and a negative net margin of 59.24%.
View eMagin's earnings history

How has eMagin's stock been impacted by Coronavirus?

eMagin's stock was trading at $0.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EMAN stock has increased by 1,000.0% and is now trading at $2.75.
View which stocks have been most impacted by COVID-19

What price target have analysts set for EMAN?

1 Wall Street analysts have issued 1 year price targets for eMagin's stock. Their forecasts range from $5.00 to $5.00. On average, they expect eMagin's share price to reach $5.00 in the next year. This suggests a possible upside of 81.8% from the stock's current price.
View analysts' price targets for eMagin
or view top-rated stocks among Wall Street analysts.

Who are eMagin's key executives?

eMagin's management team includes the following people:
  • Mr. Andrew G. Sculley Jr., CEO & Director (Age 70, Pay $352k)
  • Mr. Mark A. Koch, Acting Chief Financial Officer (Age 62, Pay $235k)
  • Dr. Amalkumar Ghosh, Chief Operating Officer (Age 67, Pay $300k)
  • Mr. Olivier Prache, Sr. VP of Product Devel. (Age 62)
  • Mr. Joseph Saltarelli, Sr. VP of Operations (Age 53)

Who are some of eMagin's key competitors?

What other stocks do shareholders of eMagin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other eMagin investors own include Guyana Goldfields (GUY), Hawkins (HWKN), CA (CA), Kopin (KOPN), Universal Display (OLED), Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), Riot Blockchain (RIOT), BlackRock (BLK) and Advanced Micro Devices (AMD).

What is eMagin's stock symbol?

eMagin trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "EMAN."

Who are eMagin's major shareholders?

eMagin's stock is owned by a number of institutional and retail investors. Top institutional investors include GWM Advisors LLC (0.10%) and Cutler Group LP (0.00%). Company insiders that own eMagin stock include Amalkumar Ghosh, Eric Braddom, Joseph Saltarelli, Ltd Enervest, Ltd Ginola, Mark A Koch, Prache Olivier and Stillwater Holdings Llc.
View institutional ownership trends for eMagin

Which institutional investors are buying eMagin stock?

EMAN stock was purchased by a variety of institutional investors in the last quarter, including GWM Advisors LLC, and Cutler Group LP. Company insiders that have bought eMagin stock in the last two years include Eric Braddom, and Mark A Koch.
View insider buying and selling activity for eMagin
or or view top insider-buying stocks.

How do I buy shares of eMagin?

Shares of EMAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is eMagin's stock price today?

One share of EMAN stock can currently be purchased for approximately $2.75.

How much money does eMagin make?

eMagin has a market capitalization of $198.75 million and generates $29.42 million in revenue each year. The semiconductor company earns $-11,450,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis.

How many employees does eMagin have?

eMagin employs 102 workers across the globe.

What is eMagin's official website?

The official website for eMagin is www.emagin.com.

Where are eMagin's headquarters?

eMagin is headquartered at 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States.

How can I contact eMagin?

eMagin's mailing address is 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States. The semiconductor company can be reached via phone at +1-845-8387900 or via email at [email protected]

This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.